I am scared, says Uma Bharati as Vyapam death count rises

July 7, 2015

New Delhi, Jul 7: The Vyapam cloud darkened over the BJP government in MP on Monday with two more deaths in the state getting linked to the admission and recruitment racket and Union water resources minister Uma Bharati saying she was scared by the spate of mysterious deaths.

uma3 bharti "There is panic in MP due to the deaths. I am scared for the lives of people connected to me. I am a minister but still I am scared. I will convey my fears to CM Shivraj Singh Chouhan," Bharati said on a day when two more persons — woman sub-inspector Anamika Kushwaha, recruited through the MP Professional Examination Board, and police constable Ramakant Pandey, a suspect in the scam — died in suspicious circumstances.

Both were said to have committed suicide. But like in other deaths connected to the scam, the explanation failed to lift the stench of conspiracy. In the case of Kushwaha, who was found in a lake in Sagar, her father refused to cry foul play, but her sister found the death suspicious.

Pandey was found hanging from a ceiling fan at a tourist police outpost in Orchha, Tikamgarh, his place of posting. He had been questioned by the Special Task Force probing the scam a few months ago. Tikamgarh SP Nimish Agarwal said Pandey, an alcoholic, had been depressed because he was saddled with mounting debt.

The two cases came after the spooky deaths of TV journalist Akshay Singh just after talking to the family of Namrata Damor, an alleged beneficiary of the admission racket who was found death near railway tracks three years ago, and Dr Arun Sharma, dean of a medical college in Jabalpur. Sharma was part of the probe into fraudulent admissions in the medical college as part of the fraud.

Uma Bharati, meanwhile, expressed resentment over being included in one of the Vyapam-related FIRs on the basis of the statement of an accused. "It is a very deep conspiracy. The biggest example of the deep conspiracy is that my name is in it. Because I have nothing to do with this. If I am there, then some very serious conspiracy is there," Bharti told PTI.

She acknowledged the overpowering sense of intrigue over the deaths, saying: "Maybe nobody is killing them. But the fear and shame of innocent people are causing brain hemorrhage, heart attack or suicide. When I heard my name in Vyapam, even I went through lot of trauma."

Bharati backed Chouhan in the face of the opposition's shrill demands for his resignation, saying he had a clean image. "I stand with Shivraj ji, I'm concerned about him as he's a sensitive person. He must be upset about these deaths," she said.

But her sympathy for her BJP colleague only underlined the trouble the Vyapam scandal has thrown up for Chouhan when he appeared to be cruising along on the strength of his solid performance as three-term CM of a state which under his tenure grew out of the 'BIMARU' club to take its place among the fast-growing ones.

The day saw BJP spokespersons aggressively rallying around the successful satrap who risks getting stained by the scam but there was a recognition that Chouhan's own credentials may not be sufficient for his defence. With the SIT set to submit its charge-sheet in the scam by July 15, there are fears of the death toll rising because of the likely desperation among the kingpins.

There are indications that the Chouhan government may agree to any suggestion by the Supreme Court to hand over the probe to the CBI -- a demand already made by Congress and others -- in order to control the damage.

Distraught by the timing of the deaths, just when they were nursing their bruises from the controversy over the links of foreign minister Sushma Swaraj and Rajasthan CM Vasundhara Raje, BJP strategists are hoping for a respite, a break from the grim pattern of Vyapam deaths on a daily basis. They are eagerly awaiting the reports of forensic tests into the deaths of Akshay Singh and Dr Sharma, hoping that the findings will rule out foul play.

Although the journalist and the doctor account for only two of a row of people who have died, findings by forensic experts that they were not killed could validate the claim that all Vyapam-linked deaths were not similar and could not be lumped.

Will expose MP CM: Whistleblower

Whistleblower Ashish Chaturvedi said on Monday he would expose MP CM Shivraj Singh Chouhan in the Vyapam scam. Reacting to a warning to him that he would be "cut into pieces", Chaturvedi told NDTV: "Even if I die as a result, I want to name the big fish — starting with Chouhan." TOI had reported on Sunday that Chaturvedi, who had been attacked 14 times, had sought more police protection.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

New Delhi, April 4: With 355 new cases reported in the last 12 hours, India's tally of coronavirus positive cases rose to 2,902, said the ministry of Health and Family Welfare on Saturday.

Out of 2,902 cases, 2,650 are active cases and 184 have been cured or discharged or have migrated.

The total number of deaths reported due to the disease rose to 68 on Saturday.

According to the Ministry of Health and Family Welfare, Maharashtra is the worst-hit state with 423 cases. Tamil Nadu is the next most affected state with 411 cases.

The number of COVID-19 cases in Delhi also rose to 386.

The Tablighi Jamaat event in Delhi has emerged as a hotspot for COVID-19 after several positive cases from across India were linked to the gathering including deaths in Maharashtra, Karnataka, and Telangana.

An FIR was earlier registered against Tablighi Jamaat head Maulana Saad and others under the Epidemic Disease Act 1897, in the national capital.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 16,2020

New Delhi, Jan 16: In trouble brewing for the Gautam Adani-led M/S Adani Enterprises, the Central Bureau of Investigation (CBI) on Thursday said that it has registered a case against former officials of the National Co-operative Consumer Federation (NCCF) and others over alleged irregularities in supply of coal to the Andhra Pradesh Power Generation Corporation (APGENCO) in 2010.

The CBI in its FIR has named Virendra Singh, the then Chairman of the NCCF, G P Gupta, the then MD of the NCCF, S C Singhal, the then Senior Advisor of NCCF, Adani Enterprises Ltd and other unknown public servants and others for criminal conspiracy, cheating and criminal misconduct by public servants.

According to CBI, the case was filed on Wednesday after the preliminary enquiry revealed the crime by the officials named in the FIR and the Adani Enterprises was found to be true.

The FIR alleged that on June 26, 2010, APGENCO floated a tender enquiry for supply of six lakh metric tonnes of imported coal "on free on rail destination" basis to Dr Narla Tata Rao Thermal Station (NTTPS), Vijaywada and Rayalasaleema Thermal Power Plant (RTTP), Kadapa, Andhra Pradesh/RTPP via Kakinada-Vizag-Chennai-Krishnapatnam or any other ports

The same was forwarded by the Chief Engineer, APGENCO to seven PSUs -- PEC Limited, STC Limited, MSTC Limited, NCCF, MMTC, Coal India Limited and SCCL Limited.

The FIR alleged that during the probe, the Adani Enterprises used a proxy company to get the supply contract. It said, "NCCF received bids from six companies -- Adani Enterprises Ltd, Maheshwari Brothers Coal Limited (MBCL), Vyom Trade Links Pvt. Ltd, Swarana Projects Pvt. Ltd, Gupta Coal India Ltd and Kyori Oremen Ltd.

During investigation it was found that Gupta Coal India Ltd had quoted the NCCF margin of 11.3 percent, while the MBCL quoted the margin of 2.25 percent and rest did not quote any margin to the NCCF.

The FIR said the quotes of the Gupta Coal India Ltd, Kyori Oremen Ltd and Swarana Projects Pvt. Ltd were rejected by the NCCF as they were not found to be fulfilling the tender conditions.

"Post tender negotiation was done by senior officials of NCCF to give undue favour to Adani Enterprises Ltd despite it not qualifing the tender (terms)," the FIR said, adding instead of cancelling the bid of Adani Enterprise Ltd, senior management of NCCF conveyed the offer margin to the company through one of its representative -- Munish Sehgal, who was sitting in the NCCF head office. It is prima facie evident that when the bids were being processed at NCCF head office in Delhi, a representative of Adani Enterprises Ltd. was informed regarding their imminent rejection due to non-submission of NCCF margin and also that MBCL was eligible bidder quoted 2.25 percent margin," it alleged.

The CBI in its FIR, further alleged that Adani Enterprises Ltd. had given an unsecured loan of Rs 16.81 crore to Vyom Trade Links Ltd in 2008-09. "And further it was revealed that the bank guarantees of the Adani Enterprises Ltd. and Vyom Trade Links Ltd. were issues by the same branch of the State Bank of India and at the same time," it said.

"It was clear that Adani Enterprises Ltd. presented Vyom Trade Links Ltd. as a proxy company in this particular tender and Vyom Trade Links Ltd. later withdrew its offer on flimsy ground," the CBI FIR said.

"The aforesaid acts of commissions and omissions on the part of the senior management of the NCCF disclose that during their tenure, they acted in a manner unbecoming of public servants and committed irregularities by way of manipulation in the selection of bidders, thereby giving undue favours to Adani Enterprises Ltd. in award of work for supply of coal to APGENCO despite its disqualification," it added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.